The hormone behind every weight-loss drug everyone is talking about.
Millions of people are injecting a GLP-1 drug right now. Most of them cannot tell you what GLP-1 is. That gap is the whole problem with how peptides get sold, and closing it is the fastest way to stop being marketed to.
GLP-1 stands for glucagon-like peptide-1. It is an incretin, a hormone your gut releases after you eat. It triggers insulin only when blood glucose is already high, which is why GLP-1 drugs rarely drive blood sugar dangerously low. It suppresses glucagon, slows how fast the stomach empties, and acts on the appetite centers of the brain. That last effect is the one users describe most, the quiet disappearance of the urge to eat.
Here is the catch that explains the entire industry built on this hormone. Your natural GLP-1 lasts about one to two minutes before an enzyme breaks it down. So semaglutide and the drugs like it are engineered to resist that breakdown and to ride a carrier protein in the blood. That single piece of engineering is why a once-weekly shot can do what a two-minute hormone never could.
In the trials, semaglutide produced average weight loss in the mid-teens as a percentage of body weight. That is the reported clinical result, and it is the reason the entire metabolic field reorganized around this one hormone. Understand GLP-1 and semaglutide stops being a black box. It becomes one hormone, made to last.
Get the Peptide Research Playbook.
Learn how to evaluate evidence, safety context, regulatory status, and sourcing standards before researching any compound. Educational only.